|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
737035 |
| 003 |
ICU |
| 005 |
19950903000000.0 |
| 008 |
860203s1985 flua b 10110 eng d |
| 010 |
|
|
|a 85047770
|
| 020 |
|
|
|a 0125862709 (alk. paper)
|
| 035 |
|
|
|a (ICU)BID9475931
|
| 035 |
|
|
|a (OCoLC)12022898
|
| 039 |
0 |
|
|a 2
|b 3
|c 3
|d 3
|e 3
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|
| 041 |
0 |
|
|a eng
|
| 050 |
0 |
|
|a QR188.6
|b .C66 1984
|
| 060 |
|
|
|a QZ 200 I332 1984
|
| 082 |
0 |
|
|a 616.99/4079
|2 19
|
| 111 |
2 |
|
|a Conference on Immunity to Cancer
|d (1984 :
|c Williamsburg, Va.)
|
| 245 |
1 |
0 |
|a Immunity to cancer /
|c edited by Arnold E. Reif, Malcolm S. Mitchell.
|
| 260 |
0 |
|
|a Orlando :
|b Academic Press,
|c 1985.
|
| 300 |
|
|
|a xvii, 659 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 500 |
|
|
|a Proceedings of the Conference on Immunity to Cancer, held at Williamsburg, Virginia, Sept. 10-12, 1984, sponsored by Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute ... et al.
|
| 504 |
|
|
|a Includes bibliographies and index.
|
| 650 |
|
0 |
|a Cancer
|x Immunological aspects
|x Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2008100050
|
| 650 |
|
0 |
|a Tumors
|x Immunological aspects
|x Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2010117205
|
| 650 |
|
0 |
|a Tumor antigens
|x Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2010117203
|
| 650 |
|
0 |
|a Immunotherapy
|x Congresses.
|
| 650 |
|
0 |
|a Biological response modifiers
|x Congresses.
|
| 650 |
|
2 |
|a Antigens, Neoplasm
|x congresses.
|
| 650 |
|
2 |
|a Immunotherapy
|x Congresses.
|
| 650 |
|
2 |
|a Neoplasms
|x immunology
|x congresses.
|
| 650 |
|
7 |
|a Biological response modifiers.
|2 fast
|0 http://id.worldcat.org/fast/fst00832312
|
| 650 |
|
7 |
|a Cancer
|x Immunological aspects.
|2 fast
|0 http://id.worldcat.org/fast/fst00845383
|
| 650 |
|
7 |
|a Immunotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00968044
|
| 650 |
|
7 |
|a Tumor antigens.
|2 fast
|0 http://id.worldcat.org/fast/fst01158748
|
| 650 |
|
7 |
|a Tumors
|x Immunological aspects.
|2 fast
|0 http://id.worldcat.org/fast/fst01158775
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
| 700 |
1 |
0 |
|a Reif, Arnold E.
|0 http://id.loc.gov/authorities/names/n85090067
|1 http://viaf.org/viaf/46836744
|
| 700 |
1 |
0 |
|a Mitchell, Malcolm S.
|0 http://id.loc.gov/authorities/names/n82057958
|1 http://viaf.org/viaf/100545
|
| 710 |
2 |
0 |
|a Biological Response Modifier Program (U.S.)
|0 http://id.loc.gov/authorities/names/n82069797
|1 http://viaf.org/viaf/152465518
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 2ebb6b05-61cd-5263-9543-901ba2bcbcaa
|s 55f929b4-fa67-5596-a853-bd4085b3fd7f
|
| 928 |
|
|
|t Library of Congress classification
|a QR188.6.C660 1984
|l ASR
|c ASR-SciASR
|i 5751232
|
| 927 |
|
|
|t Library of Congress classification
|a QR188.6.C660 1984
|l ASR
|c ASR-SciASR
|e CRERAR
|b 24719257
|i 1786973
|
